Home | Welcome to Contract Pharma   
Last Updated Tuesday, April 28 2015

Print RSS Feed

Topics - Biologics, Proteins, Vaccines

Refine by Date:
From: To:
Published April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Published April 17, 2015
Takeover expands Sartorius’ service portfolio Read More »
Published April 16, 2015
Reicin brings extensive research and leadership experience Read More »
Published April 10, 2015
Expands sterile bioprocessing portfolio Read More »
Published March 30, 2015
Merck Serono gains access to Intrexon's suite of technologies to engineer T-cells Read More »
Published March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Published March 23, 2015
To develop targeted anticancer therapeutics for as many as two undisclosed targets Read More »
Published March 16, 2015
Manufactures MVA EBOZ for Phase I trial Read More »
Published March 12, 2015
Will provide cGMP manufacture for clinical and commercial supply Read More »
Published March 9, 2015
Sandoz Zarxio approved for all indications on Filgrastim label Read More »
Published March 6, 2015
CoE in San Diego has 46,000 sq.-ft. of lab, office and sample storage space Read More »
Published March 2, 2015
Integrates continuous flow manufacturing technology Read More »
Published February 25, 2015
Opens newly expanded office Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On